Keywords: SES، sirolimus-eluting stent (s); BA, balloon angioplasty; BMS, bare-metal stent(s); CB, cutting balloon angioplasty; CCS, Canadian Cardiovascular Society; EES, everolimus-eluting stent(s); ISR, in-stent restenosis; PES, paclitaxel-eluting stent(s); SES, sirolimus-eluting stent(s); TIMI,
مقالات ISI SES، sirolimus-eluting stent (s) (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Long-Term Outcome in Patients Treated With Sirolimus-Eluting Stents in Complex Coronary Artery Lesions : 3-Year Results of the SCANDSTENT (Stenting Coronary Arteries in Non-Stress/Benestent Disease) Trial
Keywords: SES، sirolimus-eluting stent (s); BMS, bare-metal stent(s); DES, drug-eluting stents; MACE, major adverse cardiac events; MI, myocardial infarction; PCI, percutaneous coronary intervention; SES, sirolimus-eluting stent(s); TLR, target lesion revascularization
A Prospective Randomized Multicenter Comparison of Balloon Angioplasty and Infrapopliteal Stenting With the Sirolimus-Eluting Stent in Patients With Ischemic Peripheral Arterial Disease : 1-Year Results From the ACHILLES Trial
Keywords: SES، sirolimus-eluting stent (s); angioplasty; below the knee artery; critical limb disease; drug-eluting stent; peripheral arterial diseasePAD, peripheral arterial disease; PTA, percutaneous transluminal balloon angioplasty; SES, sirolimus-eluting stent(s); TLR, target lesion revasculari
Drug-eluting stent restenosis: Effect of drug type, release kinetics, hemodynamics and coating strategy
Keywords: SES، sirolimus-eluting stent (s); DES, drug-eluting stent(s); PES, paclitaxel-eluting stent(s); SES, sirolimus-eluting stent(s); SS, shear stressDrug-eluting stent; In-stent restenosis; Drug release; Shear stress; Polymer coating; Percutaneous coronary intervention
Late Restenosis Following Sirolimus-Eluting Stent Implantation
Keywords: SES، sirolimus-eluting stent (s); coronary disease; restenosis; stentsMI, myocardial infarction; MLD, minimum lumen diameter; SES, sirolimus-eluting stent(s); TLR, target lesion revascularization
Late-Term Clinical Outcomes With Zotarolimus- and Sirolimus-Eluting Stents : 5-Year Follow-Up of the ENDEAVOR III (A Randomized Controlled Trial of the Medtronic Endeavor Drug [ABT-578] Eluting Coronary Stent System Versus the Cypher Sirolimus-Eluting Cor
Keywords: SES، sirolimus-eluting stent (s); drug-eluting stent(s); percutaneous coronary intervention; zotarolimusDES, drug-eluting stent(s); MACE, major adverse cardiac event(s); MI, myocardial infarction; PES, paclitaxel-eluting stent(s); SES, sirolimus-eluting stent(s); TLR, target lesion revasc
2-Year Clinical Follow-Up From the Randomized Comparison of Biolimus-Eluting Stents With Biodegradable Polymer and Sirolimus-Eluting Stents With Durable Polymer in Routine Clinical Practice
Keywords: SES، sirolimus-eluting stent (s); restenosis; stents; thrombosisBES, biolimus-eluting stent(s); CI, confidence interval; DES, drug-eluting stent(s); HR, hazard ratio; PCI, percutaneous coronary intervention; SES, sirolimus-eluting stent(s)
Coronary Responses and Differential Mechanisms of Late Stent Thrombosis Attributed to First-Generation Sirolimus- and Paclitaxel-Eluting Stents
Keywords: SES، sirolimus-eluting stent (s); drug-eluting stent; malapposition; pathology; stent thrombosis; vascular responseBMS, bare-metal stent(s); DES, drug-eluting stent(s); LST, late stent thrombosis; PES, paclitaxel-eluting stent(s); SES, sirolimus-eluting stent(s)
Maintenance of Long-Term Clinical Benefit With Sirolimus-Eluting Stents in Patients With ST-Segment Elevation Myocardial Infarction: 3-Year Results of the SESAMI (Sirolimus-Eluting Stent Versus Bare-Metal Stent In Acute Myocardial Infarction) Trial
Keywords: SES، sirolimus-eluting stent (s); restenoses; sirolimus-eluting stent; STEMIBMS, bare-metal stent(s); CABG, coronary artery bypass grafting; MACE, major adverse cardiovascular event; MI, myocardial infarction; PCI, percutaneous coronary intervention; SES, sirolimus-eluting stent(s); ST, s
Difference of Neointimal Formational Pattern and Incidence of Thrombus Formation Among 3 Kinds of Stents: An Angioscopic Study
Keywords: SES، sirolimus-eluting stent (s); angioscopy; heterogeneity; neointimal dysfunction; stent; thrombusBMS, bare-metal stent(s); DES, drug-eluting stent(s); PES, paclitaxel-eluting stent(s); SES, sirolimus-eluting stent(s)
2-Year Clinical and Angiographic Outcomes From a Randomized Trial of Polymer-Free Dual Drug-Eluting Stents Versus Polymer-Based Cypher and Endeavor, Drug-Eluting Stents
Keywords: SES، sirolimus-eluting stent (s); polymer; restenosis; sirolimus; zotarolimusDES, drug-eluting stent(s); Dual-DES, sirolimus- and probucol-eluting stent(s); SES, sirolimus-eluting stent(s); TLR, target lesion revascularization; ZES, zotarolimus-eluting stent(s)
Heterogeneous Arterial Healing in Patients Following Paclitaxel-Eluting Stent Implantation : Comparison With Sirolimus-Eluting Stents
Keywords: SES، sirolimus-eluting stent (s); angioscope; imaging; neointima; stentBMS, bare-metal stent(s); DES, drug-eluting stent(s); LL, late loss; LST, late stent thrombosis; NIC, neointimal coverage; PES, paclitaxel-eluting stent(s); SES, sirolimus-eluting stent(s); YP, yellow plaques
Impact of Target Lesion and Nontarget Lesion Cardiac Events on 5-Year Clinical Outcomes After Sirolimus-Eluting or Bare-Metal Stenting
Keywords: SES، sirolimus-eluting stent (s); stent; restenosis; atherosclerosisBMS, bare-metal stent(s); DES, drug-eluting stent(s); MI, myocardial infarction; SES, sirolimus-eluting stent(s); TLR, target lesion revascularization
Safety and Efficacy of Biodegradable Polymer-Coated Sirolimus-Eluting Stents in “Real-World” Practice : 18-Month Clinical and 9-Month Angiographic Outcomes
Keywords: SES، sirolimus-eluting stent (s); drug-eluting stents; sirolimus; biodegradable polymer; coronary heart diseaseDES, drug-eluting stent(s); MACE, major adverse cardiac event(s); MI, myocardial infarction; PLA, polylactic acid; SES, sirolimus-eluting stent(s); TLR, target lesion revasculari
Local Determinants of Thrombus Formation Following Sirolimus-Eluting Stent Implantation Assessed by Optical Coherence Tomography
Keywords: SES، sirolimus-eluting stent (s); optical coherence tomography; thrombus; sirolimus-eluting stentsIVUS, intravascular ultrasound; MSA, minimum stent area; NUS, neointimal unevenness score; OCT, optical coherence tomography; SEI, stent eccentricity index; SES, sirolimus-eluting stent(s)
5-Year Clinical Outcomes After Sirolimus-Eluting Stent Implantation : Insights From a Patient-Level Pooled Analysis of 4 Randomized Trials Comparing Sirolimus-Eluting Stents With Bare-Metal Stents
Keywords: SES، sirolimus-eluting stent (s); drug-eluting stent; stent; restenosis; thrombosis; long termARC, Academic Research Consortium; BMS, bare-metal stent(s); DES, drug-eluting stent(s); MI, myocardial infarction; SES, sirolimus-eluting stent(s); TLR, target lesion revascularization; TVR, tar
Clinical and Angiographic Outcomes With Sirolimus-Eluting Stents in Total Coronary Occlusions : The ACROSS/TOSCA-4 (Approaches to Chronic Occlusions With Sirolimus-Eluting Stents/Total Occlusion Study of Coronary Arteries-4) Trial
Keywords: SES، sirolimus-eluting stent (s); total coronary occlusion; sirolimus-eluting stent; drug-eluting stent; fractureDES, drug-eluting stent(s); SES, sirolimus-eluting stent(s); TCO, total coronary occlusion(s); TLR, target lesion revascularization
Five-Year Follow-Up After Sirolimus-Eluting Stent Implantation : Results of the SIRIUS (Sirolimus-Eluting Stent in De-Novo Native Coronary Lesions) Trial
Keywords: SES، sirolimus-eluting stent (s); coronary disease; diabetes mellitus; restenosis; stents; thrombosisARC, Academic Research Consortium; BMS, bare-metal stent(s); MACE, major adverse cardiac event(s); MI, myocardial infarction; OR, odds ratio; SES, sirolimus-eluting stent(s); TLR, target l
Drug-Eluting Stent Thrombosis: Results From the Multicenter Spanish Registry ESTROFA (Estudio ESpañol sobre TROmbosis de stents FArmacoactivos)
Keywords: SES، sirolimus-eluting stent (s); BMS, bare-metal stent(s); DES, drug-eluting stent(s); LAD, left anterior descending artery; PES, paclitaxel-eluting stent(s); SES, sirolimus-eluting stent(s); ST, stent thrombosis; STEMI, ST-segment elevation myocardial infarction
Six-Month Comparison of Coronary Endothelial Dysfunction Associated With Sirolimus-Eluting Stent Versus Paclitaxel-Eluting Stent
Keywords: SES، sirolimus-eluting stent (s); Ach, acetylcholine; ANOVA, analysis of variance; BMS, bare-metal stent(s); DES, drug-eluting stent(s); PES, paclitaxel-eluting stent(s); SES, sirolimus-eluting stent(s)
Long-Term Clinical Benefit of Sirolimus-Eluting Stents in Patients With In-Stent Restenosis: Results of the RIBS-II (Restenosis Intra-stent: Balloon angioplasty vs. elective sirolimus-eluting Stenting) Study
Keywords: SES، sirolimus-eluting stent (s); angiography; angioplasty; restenosis; sirolimus-eluting stentsBA, balloon angioplasty; CI, confidence interval; DES, drug-eluting stent(s); HR, hazard ratio; ISR, in-stent restenosis; MI, myocardial infarction; SES, sirolimus-eluting stent(s); TVR, target
Differential Effects of Drug-Eluting Stents on Local Endothelium-Dependent Coronary Vasomotion
Keywords: SES، sirolimus-eluting stent (s); BES, biolimus A9-eluting stent(s); DES, drug-eluting stent(s); PES, paclitaxel-eluting stent(s); QCA, quantitative coronary angiography; SES, sirolimus-eluting stent(s)
Drug-Eluting Stenting Followed by Cilostazol Treatment Reduces Late Restenosis in Patients With Diabetes Mellitus : The DECLARE-DIABETES Trial (A Randomized Comparison of Triple Antiplatelet Therapy With Dual Antiplatelet Therapy After Drug-Eluting Stent
Keywords: SES، sirolimus-eluting stent (s); BMS, bare-metal stent(s); DES, drug-eluting stent(s); MACE, major adverse cardiac events; MI, myocardial infarction; PES, paclitaxel-eluting stent(s); QCA, quantitative coronary angiography; SES, sirolimus-eluting stent(s); TLR, target lesion revasculariz
Long-Term Clinical Outcomes With Sirolimus-Eluting Coronary Stents : Five-Year Results of the RAVEL Trial
Keywords: SES، sirolimus-eluting stent (s); ARC, Academic Research Consortium; BMS, bare-metal stent(s); MACE, major adverse cardiac events; MI, myocardial infarction; QCA, quantitative coronary angiography; SES, sirolimus-eluting stent(s); TLR, target lesion revascularization; TVR, target vessel r
Perioperative Management of Patients With Coronary Stents
Keywords: SES، sirolimus-eluting stent (s); AMI, acute myocardial infarction; BMS, bare-metal stent(s); CI, confidence interval; DES, drug-eluting stent(s); PCI, percutaneous coronary intervention; PES, paclitaxel-eluting stent(s); SES, sirolimus-eluting stent(s)
Increased Late Mortality After Sirolimus-Eluting Stents Versus Bare-Metal Stents in Diseased Saphenous Vein Grafts: Results From the Randomized DELAYED RRISC Trial
Keywords: SES، sirolimus-eluting stent (s); BMS, bare-metal stent(s); CI, confidence interval; MI, myocardial infarction; SES, sirolimus-eluting stent(s); SVG, saphenous vein graft(s); TLR, target lesion revascularization; TVR, target vessel revascularization
Effectiveness of Drug-Eluting Stents in Patients With Bare-Metal In-Stent Restenosis: Meta-Analysis of Randomized Trials
Keywords: SES، sirolimus-eluting stent (s); BA, balloon angioplasty; BMS, bare-metal stent(s); DES, drug-eluting stent(s); PES, paclitaxel-eluting stent(s); SES, sirolimus-eluting stent(s); TLR, target lesion revascularization
A Meta-Analysis of 16 Randomized Trials of Sirolimus-Eluting Stents Versus Paclitaxel-Eluting Stents in Patients With Coronary Artery Disease
Keywords: SES، sirolimus-eluting stent (s); CI, confidence interval; DES, drug-eluting stent(s); HR, hazard ratio; MI, myocardial infarction; PES, paclitaxel-eluting stent(s); SES, sirolimus-eluting stent(s)
One-Year Results of the SCORPIUS Study : A German Multicenter Investigation on the Effectiveness of Sirolimus-Eluting Stents in Diabetic Patients
Keywords: SES، sirolimus-eluting stent (s); BMS, bare-metal stent(s); CABG, coronary artery bypass graft; MACE, major adverse cardiac events; MLD, minimal luminal diameter; PCI, percutaneous coronary intervention; PTCA, percutaneous transluminal coronary angioplasty; SES, sirolimus-eluting stent(s)
Late and Very Late Thrombosis of Drug-Eluting Stents: Evolving Concepts and Perspectives
Keywords: SES، sirolimus-eluting stent (s); BMS, bare-metal stent(s); DES, drug-eluting stent(s); MI, myocardial infarction; PCI, percutaneous coronary intervention; PES, paclitaxel-eluting stent(s); SES, sirolimus-eluting stent(s); ST, stent thrombosis
Impact of Vessel Size on Outcome After Implantation of Sirolimus-Eluting and Paclitaxel-Eluting Stents: A Subgroup Analysis of the SIRTAX Trial
Keywords: SES، sirolimus-eluting stent (s); DES, drug-eluting stent(s); MACE, major adverse cardiac events; PCI, percutaneous coronary intervention; PES, paclitaxel-eluting stent(s); RVD, reference vessel diameter; SES, sirolimus-eluting stent(s); TLR, target lesion revascularization
Comparative Clinical Outcomes of Paclitaxel- and Sirolimus-Eluting Stents : Results From a Large Prospective Multicenter Registry—STENT Group
Keywords: SES، sirolimus-eluting stent (s); MACE, major adverse cardiac events; MI, myocardial infarction; PCI, percutaneous coronary intervention; PES, paclitaxel-eluting stent(s); SAT, subacute stent thrombosis; SES, sirolimus-eluting stent(s); ST, stent thrombosis; TVR, target vessel revasculari
Thrombosis and Drug-Eluting Stents: An Objective Appraisal
Keywords: SES، sirolimus-eluting stent (s); ARC, Academic Research Consortium; BMS, bare-metal stent(s); DES, drug-eluting stent(s); PES, paclitaxel-eluting stent(s); SES, sirolimus-eluting stent(s); ST, stent thrombosis